These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 25648911)

  • 1. Urinary monocyte chemoattractant protein-1 and hepcidin and early diabetic nephropathy lesions in type 1 diabetes mellitus.
    Fufaa GD; Weil EJ; Nelson RG; Hanson RL; Knowler WC; Rovin BH; Wu H; Klein JB; Mifflin TE; Feldman HI; Vasan RS; Kimmel PL; Kusek JW; Mauer M;
    Nephrol Dial Transplant; 2015 Apr; 30(4):599-606. PubMed ID: 25648911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma bradykinin and early diabetic nephropathy lesions in type 1 diabetes mellitus.
    Wheelock KM; Cai J; Looker HC; Merchant ML; Nelson RG; Fufaa GD; Weil EJ; Feldman HI; Vasan RS; Kimmel PL; Rovin BH; Mauer M; Klein JB;
    PLoS One; 2017; 12(7):e0180964. PubMed ID: 28700653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urine inositol pentakisphosphate 2-kinase and changes in kidney structure in early diabetic kidney disease in type 1 diabetes.
    Looker HC; Merchant ML; Rane MJ; Nelson RG; Kimmel PL; Rovin BH; Klein JB; Mauer M;
    Am J Physiol Renal Physiol; 2018 Nov; 315(5):F1484-F1492. PubMed ID: 30132343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urinary monocyte chemoattractant protein-1 (MCP-1) and connective tissue growth factor (CCN2) as prognostic markers for progression of diabetic nephropathy.
    Tam FW; Riser BL; Meeran K; Rambow J; Pusey CD; Frankel AH
    Cytokine; 2009 Jul; 47(1):37-42. PubMed ID: 19409809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary monocyte chemoattractant protein-1 and vitamin D-binding protein as biomarkers for early detection of diabetic nephropathy in type 2 diabetes mellitus.
    Shoukry A; Bdeer Sel-A; El-Sokkary RH
    Mol Cell Biochem; 2015 Oct; 408(1-2):25-35. PubMed ID: 26104579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary epidermal growth factor, monocyte chemoattractant protein-1 or their ratio as predictors for rapid loss of renal function in type 2 diabetic patients with diabetic kidney disease.
    Satirapoj B; Dispan R; Radinahamed P; Kitiyakara C
    BMC Nephrol; 2018 Sep; 19(1):246. PubMed ID: 30241508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lessons learned from studies of the natural history of diabetic nephropathy in young type 1 diabetic patients.
    Steinke JM; Mauer M;
    Pediatr Endocrinol Rev; 2008 Aug; 5 Suppl 4():958-63. PubMed ID: 18806710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Usefulness of urinary biomarkers to estimate the interstitial fibrosis surface in diabetic nephropathy with normal kidney function.
    González J; Jatem E; Roig J; Valtierra N; Ostos E; Abó A; Santacana M; García A; Segarra A
    Nephrol Dial Transplant; 2022 Oct; 37(11):2102-2110. PubMed ID: 35583251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severity of glomerulopathy predicts long-term urinary albumin excretion rate in patients with type 1 diabetes and microalbuminuria.
    Bangstad HJ; Osterby R; Hartmann A; Berg TJ; Hanssen KF
    Diabetes Care; 1999 Feb; 22(2):314-9. PubMed ID: 10333951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transforming growth factor beta 1 and monocyte chemoattractant protein-1 as prognostic markers of diabetic nephropathy.
    Shaker OG; Sadik NA
    Hum Exp Toxicol; 2013 Oct; 32(10):1089-96. PubMed ID: 23515495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Value of urinary levels of interleukin-6, epidermal growth factor, monocyte chemoattractant protein type1 and transforming growth factor β1 in predicting the extent of fibrosis lesions in kidney biopsies of patients with IgA nephropathy.
    Segarra-Medrano A; Carnicer-Caceres C; Valtierra-Carmeno N; Agraz-Pamplona I; Ramos-Terrades N; Jatem Escalante E; Ostos-Roldan E
    Nefrologia; 2017; 37(5):531-538. PubMed ID: 28946966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relationship of diabetic retinopathy to preclinical diabetic glomerulopathy lesions in type 1 diabetic patients: the Renin-Angiotensin System Study.
    Klein R; Zinman B; Gardiner R; Suissa S; Donnelly SM; Sinaiko AR; Kramer MS; Goodyer P; Moss SE; Strand T; Mauer M;
    Diabetes; 2005 Feb; 54(2):527-33. PubMed ID: 15677511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glomerular structural-functional relationship models of diabetic nephropathy are robust in type 1 diabetic patients.
    Mauer M; Caramori ML; Fioretto P; Najafian B
    Nephrol Dial Transplant; 2015 Jun; 30(6):918-23. PubMed ID: 25183630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The early natural history of nephropathy in type 1 diabetes: II. Early renal structural changes in type 1 diabetes.
    Drummond K; Mauer M;
    Diabetes; 2002 May; 51(5):1580-7. PubMed ID: 11978659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of renal hyperfiltration on urinary inflammatory cytokines/chemokines in patients with uncomplicated type 1 diabetes mellitus.
    Har R; Scholey JW; Daneman D; Mahmud FH; Dekker R; Lai V; Elia Y; Fritzler ML; Sochett EB; Reich HN; Cherney DZ
    Diabetologia; 2013 May; 56(5):1166-73. PubMed ID: 23412605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased urinary excretion of monocyte chemoattractant protein-1 in proteinuric renal diseases.
    Morii T; Fujita H; Narita T; Koshimura J; Shimotomai T; Fujishima H; Yoshioka N; Imai H; Kakei M; Ito S
    Ren Fail; 2003 May; 25(3):439-44. PubMed ID: 12803507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tubulointerstitial Fibrosis of Living Donor Kidneys Associates with Urinary Monocyte Chemoattractant Protein 1.
    Wang X; Lieske JC; Alexander MP; Jayachandran M; Denic A; Mathew J; Lerman LO; Kremers WK; Larson JJ; Rule AD
    Am J Nephrol; 2016; 43(6):454-9. PubMed ID: 27288357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Associations of urinary epidermal growth factor and monocyte chemotactic protein-1 with kidney involvement in patients with diabetic kidney disease.
    Wu L; Li XQ; Chang DY; Zhang H; Li JJ; Wu SL; Zhang LX; Chen M; Zhao MH
    Nephrol Dial Transplant; 2020 Feb; 35(2):291-297. PubMed ID: 30357416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated Urinary VEGF-A, Transferrin, and Angiotensinogen Levels in Normoalbuminuric Children and Adolescents with Type 1 Diabetes: Can They Be Early Markers of Diabetic Kidney Disease?
    Dağdeviren Çakır A; Saygılı SK; Canpolat N; Konukoğlu D; Turan H; Çalışkan S; Sever L; Ercan O; Evliyaoğlu O
    Horm Res Paediatr; 2021; 94(11-12):426-432. PubMed ID: 34915504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Five-year prospective study of glomerular filtration rate and albumin excretion rate in normofiltering and hyperfiltering normoalbuminuric NIDDM patients.
    Silveiro SP; Friedman R; de Azevedo MJ; Canani LH; Gross JL
    Diabetes Care; 1996 Feb; 19(2):171-4. PubMed ID: 8718441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.